| Company Name: |
Aikon International Limited
|
| Tel: |
025-66113011 13155353615 |
| Email: |
qzhang@aikonchem.com |
| Products Intro: |
Product Name:(4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE
CAS:214287-88-4
Purity:95+% Package:1g;5g;10g
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:DPC 961
CAS:214287-88-4
Purity:NULL Package:50mg;5mg Remarks:NULL
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:DPC-961;DPC961,DPC 961
CAS:214287-88-4
Purity:98% Package:5 mg
|
| Company Name: |
Suzhou Meishi Biotechnology Co., Ltd.
|
| Tel: |
1173954148q |
| Email: |
meishipharma@126.com |
| Products Intro: |
Product Name:214287-88-4
CAS:214287-88-4
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
|
|
| | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE Basic information |
| Product Name: | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE | | Synonyms: | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE;(4S)-6-Chloro-4-(2-cyclopropylethynyl)-3,4-dihydro-4-(trifluoromethyl)-2(1H)-quinazolinone;(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1,3-dihydroquinazolin-2-one;2(1H)-Quinazolinone, 6-chloro-4-(2-cyclopropylethynyl)-3,4-dihydro-4-(trifluoromethyl)-, (4S)-;DMP 961;DMP961;DMP-961;DPC961,DPC 961 | | CAS: | 214287-88-4 | | MF: | C14H10ClF3N2O | | MW: | 314.69 | | EINECS: | | | Product Categories: | | | Mol File: | 214287-88-4.mol |  |
| | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE Chemical Properties |
| solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | color | White |
| | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE Usage And Synthesis |
| Uses | DPC 961 is a novel anti-HIV drug used in the treatment of the affliction. Used as a non-nucleoside reverse-transcriptase inhibitor, it helps control the replication of genetic material. |
| | (4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE Preparation Products And Raw materials |
|